Antibiotics

>

Latest News

The Aminoglyco-Side Hustle: What’s Now and Next in Gram-Negative Infections
The Aminoglyco-Side Hustle: What’s Now and Next in Gram-Negative Infections

September 5th 2025

In the midst of many changes surrounding aminoglycosides over the past several years, clinicians may be left wondering if these agents still have a role in modern clinical practice. This article summarizes changes impacting aminoglycosides, discusses where these agents may still have a role in the context of gram-negative infections, and explores future areas of study.

PCR Testing of Pneumonia in ICU Improves Treatment Costs but Not Cure Rate
PCR Testing of Pneumonia in ICU Improves Treatment Costs but Not Cure Rate

September 4th 2025

Oral Antibiotic Launches for Uncomplicated UTIs
Oral Antibiotic Launches for Uncomplicated UTIs

September 3rd 2025

Oral Antibiotic Proves Non-Inferior to Injectable and Oral Regimen for Bubonic Plague
Oral Antibiotic Proves Non-Inferior to Injectable and Oral Regimen for Bubonic Plague

September 1st 2025

A Rare Pediatric Case: Recurrent Corynebacterium pseudotuberculosis Central Line–Associated Bloodstream Infection
A Rare Pediatric Case: Recurrent Corynebacterium pseudotuberculosis Central Line–Associated Bloodstream Infection

August 25th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.